2013 American Transplant Congress
Survival after Late Hepatic Artery Thrombosis
Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
Introduction:Hepatic artery thrombosis (HAT) is associated with poor outcome. In reporting one of the largest series of late HAT our goal is to determine the…2013 American Transplant Congress
Long Term Outcomes of Incidentally Discovered Hepatocellular Carcinoma
Background: The risk of hepatocellular carcinoma (HCC) is increased in patients with cirrhosis as a result of any chronic liver disease. Current guidelines recommend HCC…2013 American Transplant Congress
Arachidonate Lipoxygenase Controls the Suppressive Function of Myeloid Derived Suppressor Cells
The Mount Sinai School of Medicine, New York, NY
Background: Myeloid derived suppressor cells (MDSC) are myeloid cells with suppressive function, a definition that reflects both their origin and function. MDSC represent a heterogeneous…2013 American Transplant Congress
Long-Term Risk of ESRD Attributable to Live Kidney Donation: Matching with Healthy Non-Donors
Background Higher rates of ESRD post-donation have been reported in African-American donors than in white donors, but no studies have compared ESRD incidence in donors…2013 American Transplant Congress
Standardization of CMV DNA Viral Load Monitoring
Background: The clinical utility of cytomegalovirus (CMV) viral load (VL) testing for managing transplant recipients and other immunocompromised patients has been established based on the…2013 American Transplant Congress
YAP Phosphorylation Is Altered during Liver Regeneration in a Rat Hepatectomy Model
Purpose:The transcription factor YAP has been shown to stimulate hepatocyte proliferation. Furthermore, overexpression of YAP results in liver overgrowth leading to transformation into malignancy. Phosphorylation…2013 American Transplant Congress
Are Preemptive Deceased Donor Kidney Transplants Equitable?
University of Chicago, Chicago, IL
Background: The UNOS kidney allocation policy has evolved since first introduced in the 1980s. In 2002 there was a reduction in the number of points…2013 American Transplant Congress
Does Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis Affect Outcomes in Kidney Transplant Recipients?
Solid Organ Transplant, University of Utah Health Care, Salt Lake City, UT
INTRODUCTION: Valganciclovir (VGC) is used for CMV ppx in kidney tx recipients (KTR). Based on previous PK and efficacy studies, a lower potential for AEs…2013 American Transplant Congress
Results of Response Guided Therapy (RGT) Using Telaprevir in Liver Transplant Recipients with Hepatitis C Virus (HCV) Recurrence: A Single Center Experience of 18 Patients
The Liver Institute, Methodist Dallas Medical Center, Dallas, TX
Introduction: There is no data on response guided therapy in liver transplant recipients with HCV genotype I recurrence.Aim: This is a Clinical Protocol developed to…2013 American Transplant Congress
MicroRNA 194 Regulates Apoptosis in Epstein Barr Virus+ B Cell Lymphomas Associated with Post-Transplant Lymphoproliferative Disorder
Surgery, Stanford University School of Medicine, Stanford, CA
Post-Transplant Lymphoproliferative Disease (PTLD) is a potentially fatal side effect of the immunosuppressive agents used to prevent allograft rejection. PTLD is associated with Epstein-Barr Virus…
American Transplant Congress abstracts